AWM
NBIX icon

Avior Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Avior Wealth Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Buy
+2,979
New +$442K 0.01% 519
2025
Q1 		– Sell
-22
Closed -$3K – 1754
2024
Q4 		$3K Buy
+22
New +$2.72K ﹤0.01% 2033
2024
Q3 		– Sell
-3,360
Closed -$463K – 2376
2024
Q2 		$463K Sell
3,360
-824
-20% -$113K 0.02% 455
2024
Q1 		$577K Sell
4,184
-43
-1% -$5.87K 0.03% 404
2023
Q4 		$557K Sell
4,227
-282
-6% -$32.5K 0.03% 319
2023
Q3 		$507K Buy
4,509
+1,924
+74% +$203K 0.03% 326
2023
Q2 		$244K Buy
2,585
+414
+19% +$40.5K 0.02% 488
2023
Q1 		$220K Sell
2,171
-111
-5% -$11.6K 0.02% 513
2022
Q4 		$273K Sell
2,282
-1,602
-41% -$188K 0.02% 419
2022
Q3 		$412K Sell
3,884
-561
-13% -$56.9K 0.03% 314
2022
Q2 		$433K Sell
4,445
-1,387
-24% -$128K 0.04% 277
2022
Q1 		$546K Sell
5,832
-3,139
-35% -$266K 0.05% 280
2021
Q4 		$764K Buy
8,971
+835
+10% +$76.8K 0.06% 243
2021
Q3 		$780K Buy
8,136
+1,035
+15% +$97.8K 0.06% 225
2021
Q2 		$691K Buy
7,101
+71
+1% +$6.8K 0.07% 232
2021
Q1 		$683K Buy
7,030
+915
+15% +$95.9K 0.07% 231
2020
Q4 		$586K Buy
6,115
+860
+16% +$83.1K 0.07% 234
2020
Q3 		$504K Buy
5,255
+450
+9% +$52.1K 0.07% 232
2020
Q2 		$585K Buy
4,805
+100
+2% +$11.1K 0.09% 203
2020
Q1 		$406K Buy
4,705
+4,660
+10,356% +$456K 0.08% 227
2019
Q4 		$4K Buy
+45
New +$4.71K ﹤0.01% 670
2019
Q2 		– Sell
-3,030
Closed -$266K – 859
2019
Q1 		$266K Buy
3,030
+910
+43% +$76.1K 0.06% 302
2018
Q4 		$151K Buy
2,120
+910
+75% +$87.2K 0.04% 372
2018
Q3 		$149K Sell
1,210
-1,279
-51% -$145K 0.03% 402
2018
Q2 		$245K Buy
2,489
+1,258
+102% +$113K 0.06% 278
2018
Q1 		$102K Buy
1,231
+111
+10% +$9.37K 0.02% 439
2017
Q4 		$87K Buy
+1,120
New +$76.4K 0.02% 451

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Avior Wealth Management's NBIX Position: Q2 2026 in Review

Avior Wealth Management opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 2,979 shares worth $502K. The stake represents 0.01% of the portfolio and ranks #519 among its holdings. This is a return to the name: Avior Wealth Management previously reported a position in NBIX as recently as Q4 2024.

Avior Wealth Management first reported a position in NBIX in Q4 2017 and has held it in 27 quarters since. The position peaked at $780K in Q3 2021. 78 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Avior Wealth Management held 2,979 shares of Neurocrine Biosciences worth $502K as of Q2 2026.
  • Neurocrine Biosciences was a new Avior Wealth Management position in Q2 2026.
  • Neurocrine Biosciences made up 0.01% of Avior Wealth Management's portfolio in Q2 2026, its #519 holding.
  • Avior Wealth Management first reported a position in Neurocrine Biosciences in Q4 2017 and has held it in 27 quarters since.
  • Avior Wealth Management's Neurocrine Biosciences position peaked at $780K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.